GILD · Categories · Coverage
GILD - Analyst coverage initiated
Gilead Sciences Inc. (GILD) analyst coverage initiated - real-time wire coverage filtered to Coverage only.
Recent Coverage for GILD
- Jefferies initiated coverage on Gilead Sciences with a new price targetJefferies initiated coverage of Gilead Sciences with a rating of Buy and set a new price target of $180.00
- Barclays initiated coverage on Gilead Sciences with a new price targetBarclays initiated coverage of Gilead Sciences with a rating of Equal Weight and set a new price target of $155.00
- Scotiabank initiated coverage on Gilead Sciences with a new price targetScotiabank initiated coverage of Gilead Sciences with a rating of Sector Outperform and set a new price target of $140.00
- Wolfe Research initiated coverage on Gilead Sciences with a new price targetWolfe Research initiated coverage of Gilead Sciences with a rating of Outperform and set a new price target of $110.00
- Citigroup initiated coverage on Gilead Sciences with a new price targetCitigroup initiated coverage of Gilead Sciences with a rating of Buy and set a new price target of $125.00
- Bernstein initiated coverage on Gilead Sciences with a new price targetBernstein initiated coverage of Gilead Sciences with a rating of Outperform and set a new price target of $105.00
- Deutsche Bank initiated coverage on Gilead Sciences with a new price targetDeutsche Bank initiated coverage of Gilead Sciences with a rating of Hold and set a new price target of $75.00
- HSBC Securities initiated coverage on Gilead Sciences with a new price targetHSBC Securities initiated coverage of Gilead Sciences with a rating of Reduce and set a new price target of $71.00
- Cantor Fitzgerald initiated coverage on Gilead Sciences with a new price targetCantor Fitzgerald initiated coverage of Gilead Sciences with a rating of Neutral and set a new price target of $70.00
- SVB Leerink initiated coverage on Gilead Sciences with a new price targetSVB Leerink initiated coverage of Gilead Sciences with a rating of Mkt Perform and set a new price target of $68.00
- Goldman Sachs initiated coverage on Gilead Sciences with a new price targetGoldman Sachs initiated coverage of Gilead Sciences with a rating of Neutral and set a new price target of $80.00